
Accustem Sciences Inc. Share · US00444A1016 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Accustem Sciences Inc.
No Price
Closing Price OTC 30.04.2026:
0,28 USD
30.04.2026 20:00
Current Prices from Accustem Sciences Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
ACUT
|
USD
|
30.04.2026 20:00
|
0,28 USD
| 0,00 USD |
Company Profile for Accustem Sciences Inc. Share
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.
Company Data
Name Accustem Sciences Inc.
Company Accustem Sciences Inc.
Website
https://www.accustem.com
Primary Exchange
UTC
ISIN US00444A1016
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Wendy E. Blosser
Country United States of America
Currency USD
Employees 0,0 T
Address 5 Penn Plaza, 10001 New York City
IPO Date 2022-03-03
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ACUT |
More Shares
Investors who hold Accustem Sciences Inc. also have the following shares in their portfolio:

